Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

PneumoLLM: Harnessing the power of large language model for pneumoconiosis diagnosis.

Song M. et al, (2024), Medical image analysis, 97

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity

Hamid MHBA. et al, (2024), Nature Immunology

Clinical identification of malignant pleural effusions.

Jia J. et al, (2023), Translational oncology, 39

Achieving Molecular Profiling in Pleural Biopsies

Sundaralingam A. et al, (2023), Chest, 163, 1328 - 1339

Reply to Yasuma et al.

Bedawi EO. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 950 - 950

The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study

Bedawi EO. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 731 - 739

Editorial: Reviews in thoracic oncology

Kanellakis NI., (2023), Frontiers in Oncology, 13

Malignant pleural effusion: Updates in diagnosis, management and current challenges

Addala DN. et al, (2022), Frontiers in Oncology, 12

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Evans RA. et al, (2022), The Lancet Respiratory Medicine, 10, 761 - 775

The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing

Kanellakis NI. et al, (2022), The Lancet Microbe, 3, e294 - e302

Objective Thoracoscopic Criteria in Differentiation between Benign and Malignant Pleural Effusions

Ellayeh M. et al, (2022), Respiration, 101, 46 - 56

The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma

Asciak R. et al, (2021), Chest, 160, 1925 - 1933

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

Asciak R. et al, (2021), Frontiers in Oncology, 11

Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?

Guariglia A. et al, (2020), Breathe (Sheffield, England), 16

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments

Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008

Osteopontin drives KRAS-mutant lung adenocarcinoma

Giopanou I. et al, (2020), Carcinogenesis, 41, 1134 - 1144

Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set

Mercer RM. et al, (2020), Respirology, 25, 750 - 755

Intercostal vessel screening prior to pleural interventions by the respiratory physician: a prospective study of real world practice

Bedawi EO. et al, (2020), European Respiratory Journal, 55, 1902245 - 1902245

In vitro and in vivo laboratory models

Yao X. and Kanellakis NI., (2020), ERS Monograph, 2020, 29 - 47

Management of incidental nodules in lung cancer screening: ready for prime-time?

Kanellakis NI. and Lamote K., (2019), Breathe, 15, 346 - 349

Load More

Include forthcoming?